The drugmaker concluded the COVID vaccine is 76% effective in preventing symptomatic COVID-19

AstraZeneca insists that its COVID-19 vaccine is strongly effective even after counting additional illnesses in its U.S. study, the latest in an extraordinary public dispute with American officials.